All Articles

Crypto exchange Phemex now offers 24/7 stock and metal futures, a bold move to unify markets that also navigates a complex and risky regulatory maze.

With investors watching, Lincoln Electric's CEO and CFO will detail their vision for automation, global growth, and financial performance at a key conference.

The warehouse club operator signals robust confidence with a major dividend hike and plans for four new stores, pushing its stock to near-record highs.

With a major mine online in Korea and a new US acquisition, Almonty Industries is poised to break China's tungsten monopoly amid record prices.

How tech PR agency Wireside Communications turned a people-first culture into a banner year of industry awards, setting a new benchmark for success.

Amid soaring aerospace demand and strong financials, the critical component supplier will outline its tech and market strategy at its March 10 investor day.

As Dauch Corp, formerly American Axle, prepares its Q4 results, all eyes are on its powertrain-agnostic strategy and the integration of Dowlais Group.

EMD Serono and the Trump Administration launch a new program offering massive discounts on IVF drugs, bringing hope to millions of aspiring parents.

Eastern Platinum has secured new insider financing to boost production at its South African mine, highlighting its reliance on related-party deals for growth.

Karat Packaging rewards investors with a $0.45 quarterly dividend, but can the high-yield payout be sustained amid rising costs and shrinking margins?

Emirates Flight Catering's massive new biodigester system from Power Knot processes tonnes of daily food waste, setting a new sustainability standard.

The deal combines Remsoft's analytics with INFLOR's forest management system, creating a powerful end-to-end platform for the global forestry value chain.

With its stock soaring, AGF Management renews its buyback plan to repurchase 10% of its public float, a strategic move to boost value and manage dilution.

Delonix Bioworks' next-gen meningitis B vaccine, DX-104, is cleared for human trials in China and Australia, aiming to challenge the market leaders.

With rapid trial enrollment for a novel drug, Pulmovant offers a potential lifeline for patients with PH-ILD, a condition with few to no options.

Denver-based AAI secures major private equity backing to scale its tech-driven platform, promising rapid expansion and enhanced support for independent agents.

Marex's acquisition of Webb Traders signals a major push into automated equity derivatives, aiming to internalize hedging and challenge market norms.

The fintech firm is pivoting hard into digital assets, planning to mine Bitcoin Cash while launching a novel crypto life insurance business in Bermuda.

Aucta Pharma launches two rare disease drugs, PYQUVI and ZELVYSIA, betting on a 'branded-generic' model to navigate highly competitive markets.

Backed by a major investment from Nuveen, TurnClear launches to offer water 'Treatment-as-a-Service,' helping industries cut costs and meet regulations.